Notice Number: NOT-HD-20-002
Key Dates
Release Date: January 16, 2020
Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-18-214 "Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" will be extended by one receipt cycle.
The FOA has been modified as follows:
Key Dates
Currently reads:
Letter of Intent Due Date(s) 30 days prior to the application due date
Application Due Date(s) April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020
Scientific Merit Review July 2018, October 2018, March 2019, July 2019, October 2019, March 2020, July 2020
Advisory Council Review October 2018, January 2019, May 2019, October 2019, January 2020, May 2020, October 2020
Earliest Start Date December 2018, April 2019, July 2019, December 2019, April 2020, July 2020, December 2020
Expiration Date April 4, 2020
Modified to read:
Application Due Date(s) April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, August 7, 2020
Scientific Merit Review July 2018, October 2018, March 2019, July 2019, October 2019, March 2020, July 2020, October 2020
Advisory Council Review October 2018, January 2019, May 2019, October 2019, January 2020, May 2020, October 2020, January 2021
Earliest Start Date December 2018, April 2019, July 2019, December 2019, April 2020, July 2020, December 2020, April 2021
Expiration Date August 8, 2020
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Zhaoxia, M.D., Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-9340
Email: [email protected]
and Human Services (HHS)
